a Centre for Global Vaccine Research, Institute of Infection and Global Health , University of Liverpool , Liverpool , UK.
b NIHR Health Protection Research Unit for Emerging and Zoonotic Infections , University of Liverpool , Liverpool , UK.
Hum Vaccin Immunother. 2018 Jan 2;14(1):213-217. doi: 10.1080/21645515.2017.1380756. Epub 2017 Dec 21.
Japanese encephalitis (JE) is the most commonly diagnosed viral encephalitis in Asia. JE is caused by a virus called JE virus (JEV), a member of the genus Flavivirus, family Flaviviridae, and is transmitted by Culex mosquitoes. Neutralising antibody to JEV protects against JE, and can be induced by vaccination. JE is a potential threat to travellers to endemic areas, which are most of South and Southeast Asia and some Pacific Islands. The risk of JE can be expected to increase with increasing mosquito exposure and time spent in regions and seasons of active transmission. JE is very rare in travellers, but mortality is high, around 1 in 3, and there is a high rate of lasting neurological damage. JE can therefore be a profoundly life changing event for a traveller. Travellers and their healthcare providers need to balance the low risk of disease against the very high severity of disease if it does occur. In order to make an informed decision, the severity of JE disease should be carefully explained to travellers to Asia.
日本脑炎(JE)是亚洲最常见的病毒性脑炎。JE 是由一种名为日本脑炎病毒(JEV)的病毒引起的,属于黄病毒属、黄病毒科,由库蚊传播。针对 JEV 的中和抗体可预防 JE,可通过疫苗接种诱导产生。JE 对前往流行地区的旅行者构成潜在威胁,这些地区主要在南亚和东南亚以及一些太平洋岛屿。JE 的风险预计会随着蚊虫暴露的增加以及在活跃传播的地区和季节停留的时间而增加。JE 在旅行者中非常罕见,但死亡率很高,约为 1/3,且存在很高的持续性神经损伤率。因此,JE 可能会对旅行者的生活产生深远的改变。旅行者及其医疗保健提供者需要权衡疾病的低风险与疾病发生时的极高严重程度。为了做出明智的决策,应向前往亚洲的旅行者仔细说明 JE 疾病的严重程度。